Last updated on June 2019

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Brief description of study

The purpose of this study is to find out whether it is better to receive a new drug, MEDI4736, or better to receive no further treatment after surgery (and possibly chemotherapy) for lung cancer.

Clinical Study Identifier: NCT02273375

Find a site near you

Start Over

National Jewish Health

Denver, CO United States
  Connect »

University of Florida

Gainesville, FL United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Campbelltown Hospital

Campbelltown, Australia
  Connect »

Gosford Hospital

Gosford, Australia
  Connect »

Nepean Hospital

Kingswood, Australia
  Connect »

Westmead Hospital

Westmead, Australia
  Connect »

Austin Hospital

Heidelberg, Australia
  Connect »

Algoma District Cancer Program

Sault Ste. Marie, ON Canada
  Connect »

Niagara Health System

St. Catharines, ON Canada
  Connect »

CRLCC - Paoli-Calmette

Marseille Cedex, France
  Connect »

Hopital Jean Minjoz

Besancon Cedex, France
  Connect »

HIA Percy

Clamart, France
  Connect »

Clermont-Ferrand - CHU

Clermont-Ferrand, France
  Connect »

Meaux -CH

Meaux, France
  Connect »

Saint-Brieuc - CHG

Saint-Brieuc, France
  Connect »

Villefranche sur Saone - CH

Villefranche Sur Saone, France
  Connect »

Ajou University Hospital

Suwon, Korea, Republic of
  Connect »

Inje University Ilsan paik Hospital

Gyeonggi do, Korea, Republic of
  Connect »

Uijeongbu ST Marys Hospital

Gyeonggi-do, Korea, Republic of
  Connect »

Kangbuk Samsung Hospital

Seoul, Korea, Republic of
  Connect »


Zwolle, Netherlands
  Connect »

UMC Groningen

Groningen, Netherlands
  Connect »

Christchurch Hospital

Christchurch, New Zealand
  Connect »

Hospital Son Llatzer

Palma de Mallorca, Spain
  Connect »

E-Da Hospital

Kaohsiung City, Taiwan
  Connect »

St. Vincent's Hospital

Victoria Park, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.